LONDON, UK: Agronomics, a UK-based company focused on cellular agriculture, has announced that it has invested €4 million in Meatable, a Dutch company that produces cultivated pork from animal cells.
The investment is part of Meatable’s €35 million Series B financing round, which was co-led by Agronomics and New Agrarian, a new fund dedicated to alternative proteins.
Meatable uses its patented opti-ox™ technology and pluripotent stem cells to grow real muscle and fat cells in only eight days, 30 times faster than conventional pork production. The company aims to launch its first products, sausages and pork dumplings, in Singapore in 2024, and to expand into the US and Europe. Meatable has also partnered with Esco Aster Pye Ltd, the first licensed cultivated meat manufacturer in Singapore, and Love Handle SC, a plant-based butcher.
Agronomics has been an early investor in Meatable since 2019 and now holds a 6.7% stake in the company. The investment reflects Agronomics’ confidence in Meatable’s technology and vision to make cultivated meat available for everyone, without harming animals, people or the planet. Agronomics also holds equity stakes in other cellular agriculture companies, such as BlueNalu, Mosa Meat and Shiok Meats.
Agronomics invests AUD 2.5 million in HydGene Renewables to advance green hydrogen production